IBM
IBM · What the business does, what can go wrong, and how options sellers approach it
What it does
IBM sells technology and technical expertise to large organizations. Its main lines are software, consulting, and infrastructure (including mainframe computers). Customers are mostly big enterprises and governments that run complex, mission-critical systems.
Software includes Red Hat, which supports hybrid cloud computing, along with automation, data, and security tools and AI tools for businesses. Consulting helps clients redesign and modernize their technology. Infrastructure covers mainframes and related hardware and support.
How it makes money
IBM earns revenue from software subscriptions and licenses, consulting fees, and hardware sales plus ongoing maintenance and support. Much of its software and infrastructure revenue is recurring, because clients keep these systems running for years. Consulting is more project-based and tends to track corporate spending on technology.
Why investors own it
Investors often view IBM as a mature, cash-generating technology company with a long record of paying dividends. The shift toward software, especially hybrid cloud and AI-related offerings, is the core of the growth story. Its deep ties to large enterprises can make revenue relatively steady. Some see it as a more defensive way to get technology exposure, though that is not guaranteed.
What can go wrong
- Legacy businesses can shrink faster than newer ones grow.
- Cloud and AI competition is intense, and larger or nimbler rivals may take share.
- Consulting demand can weaken when clients cut technology budgets.
- Mainframe sales come in cycles tied to product refreshes.
- Acquisitions can be hard to integrate and may not pay off.
- Currency swings affect results because IBM sells worldwide.
What to watch
- Software revenue growth and recurring revenue trends
- Red Hat performance
- Consulting bookings and backlog
- Mainframe product cycle timing
- Free cash flow and dividend coverage
- Management commentary on AI demand
- Progress on cost programs and acquisitions
Options income angle
Options on IBM are generally liquid, especially near-the-money contracts in the nearest few expirations, though trading is usually less active than in the largest mega-cap tech names. Implied volatility tends to rise ahead of quarterly earnings and when investors debate AI or cloud competition. It usually settles after results are released.
One caution for premium sellers: IBM has at times moved sharply after earnings. A covered call or cash-secured put that spans an earnings date can lead to a large loss or capped upside if the stock gaps. Check the earnings calendar before choosing an expiration.
This is educational content, not investment advice.
What the latest 10-Q says
A plain-English read of Management's Discussion (and any new or changed risk factors) in the 10-Q for the quarter ended September 30, 2026, filed October 22, 2026. Figures are as the filing reports them. Read the filing on SEC.gov
The quarter in brief
IBM reported third-quarter revenue of $17.1 billion, up 4.7 percent as reported and 5.6 percent adjusted for currency. Software drove the growth, helped by the Confluent acquisition and by large deals that missed second-quarter closing timelines and closed in this quarter. Income from continuing operations rose 26.1 percent, partly because the prior-year quarter included a one-time, non-cash tax charge.
How the business did
- Quarter results: Revenue was $17,103 million versus $16,331 million a year earlier. Diluted earnings per share from continuing operations were $2.31 versus $1.84. On an operating (non-GAAP) basis, which strips out acquisition-related charges and certain pension costs, they were $2.95 versus $2.65. Gross profit margin was 56.8 percent, down 0.5 points.
- Segments: Software revenue of $7,804 million rose 8.2 percent. Data grew 19.1 percent on Confluent and Hybrid Cloud grew 10.6 percent, while Automation fell 3.3 percent. Consulting revenue of $5,335 million was essentially flat, and its segment profit margin fell to 12.2 percent. Infrastructure revenue of $3,707 million rose 4.2 percent. IBM Z fell 19.6 percent on product cycle dynamics after the z17 launch, while Distributed Infrastructure rose 31.3 percent.
- Nine months: Revenue was $50,182 million, up 4.9 percent as reported and 4.2 percent adjusted for currency. Diluted earnings per share from continuing operations were $5.86, or $7.79 on an operating basis.
- Cash and capital: Cash from operations was $11,791 million for the nine months and free cash flow was $7,787 million. Dividends were $4,762 million, and acquisitions, including Confluent, were $11,364 million. Cash, restricted cash and marketable securities were $11,106 million, down $3,364 million from year-end 2025. Total debt was $63,817 million, up $2,557 million.
What management is watching
- Investment: Research and development expense rose 14.2 percent in the quarter, driven by AI, hybrid cloud and quantum. Management plans to invest more than $10 billion in quantum over five years, and the company completed an agreement for a $1 billion CHIPS award to its Anderon subsidiary.
- Metrics pointed to: Software annual recurring revenue (ARR) was $24.9 billion. ARR is the current quarter's recurring revenue multiplied by four, so it is not a forecast of recognized revenue. Consulting signings were $5,030 million, down 3.7 percent, with backlog of $30.2 billion and a trailing twelve-month book-to-bill ratio of approximately 1.04. Management also uses free cash flow to judge results and plan shareholder returns.
- Outlook: The filing gives no numeric targets. Management calls the economic and geopolitical environment dynamic and says productivity initiatives fund investment and dividends. It also says currency swings are difficult to predict, since not all exposures are hedged.
Follow IBM in Kortex
The Kortex app shows IBM's price, options chain and IV rank, and answers your questions from live market data and SEC filings.
Free to download.
Learn the strategies
More stock briefs
For education only, not financial advice. Options involve risk and are not suitable for every investor.